 Vienna Brunt
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasodilation | 16 | 2024 | 479 | 2.640 |
Why?
| | Hyperthermia, Induced | 5 | 2021 | 109 | 2.400 |
Why?
| | Hot Temperature | 12 | 2021 | 364 | 2.130 |
Why?
| | Vascular Stiffness | 7 | 2024 | 476 | 1.970 |
Why?
| | Aging | 12 | 2024 | 1772 | 1.940 |
Why?
| | Methylamines | 5 | 2022 | 27 | 1.930 |
Why?
| | Gastrointestinal Microbiome | 5 | 2024 | 636 | 1.910 |
Why?
| | Endothelium, Vascular | 9 | 2024 | 872 | 1.760 |
Why?
| | Skin | 9 | 2017 | 719 | 1.550 |
Why?
| | Vascular Diseases | 3 | 2023 | 236 | 1.480 |
Why?
| | Drinking Water | 2 | 2022 | 76 | 1.470 |
Why?
| | Nitric Oxide | 9 | 2023 | 886 | 1.250 |
Why?
| | Cardiovascular Diseases | 5 | 2024 | 2024 | 1.150 |
Why?
| | Microcirculation | 4 | 2017 | 137 | 1.050 |
Why?
| | Potassium Channels, Calcium-Activated | 3 | 2016 | 11 | 0.960 |
Why?
| | Hyperemia | 4 | 2014 | 48 | 0.960 |
Why?
| | Acetylcholine | 5 | 2022 | 183 | 0.950 |
Why?
| | Oxidative Stress | 3 | 2021 | 1192 | 0.950 |
Why?
| | Brachial Artery | 5 | 2021 | 206 | 0.930 |
Why?
| | Carotid Arteries | 6 | 2024 | 207 | 0.870 |
Why?
| | Aorta | 4 | 2024 | 407 | 0.840 |
Why?
| | Lyases | 1 | 2022 | 9 | 0.800 |
Why?
| | Progesterone | 3 | 2013 | 244 | 0.790 |
Why?
| | Blood Pressure | 6 | 2021 | 1735 | 0.770 |
Why?
| | Femoral Artery | 2 | 2020 | 174 | 0.750 |
Why?
| | Steam Bath | 1 | 2021 | 1 | 0.740 |
Why?
| | Hydrotherapy | 1 | 2021 | 8 | 0.740 |
Why?
| | Immersion | 2 | 2021 | 6 | 0.730 |
Why?
| | Skin Physiological Phenomena | 4 | 2017 | 25 | 0.720 |
Why?
| | Estradiol | 3 | 2013 | 497 | 0.690 |
Why?
| | Cardiovascular System | 2 | 2021 | 139 | 0.680 |
Why?
| | Blood Flow Velocity | 5 | 2021 | 411 | 0.680 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2020 | 29 | 0.650 |
Why?
| | Frailty | 1 | 2022 | 153 | 0.650 |
Why?
| | Pulse Wave Analysis | 5 | 2023 | 252 | 0.620 |
Why?
| | Sarcopenia | 1 | 2020 | 74 | 0.610 |
Why?
| | Vasodilator Agents | 5 | 2024 | 322 | 0.560 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 249 | 0.540 |
Why?
| | Mice, Inbred C57BL | 8 | 2024 | 5285 | 0.540 |
Why?
| | Biological Factors | 2 | 2013 | 37 | 0.500 |
Why?
| | Acclimatization | 1 | 2017 | 160 | 0.500 |
Why?
| | Arteries | 4 | 2024 | 267 | 0.480 |
Why?
| | Skin Temperature | 2 | 2012 | 31 | 0.460 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2022 | 2065 | 0.460 |
Why?
| | Young Adult | 15 | 2024 | 12389 | 0.450 |
Why?
| | Reperfusion Injury | 1 | 2016 | 263 | 0.440 |
Why?
| | Heart | 2 | 2018 | 639 | 0.430 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 458 | 0.430 |
Why?
| | Hemodynamics | 2 | 2021 | 1084 | 0.430 |
Why?
| | Pressoreceptors | 1 | 2013 | 21 | 0.420 |
Why?
| | Mice | 12 | 2024 | 16652 | 0.420 |
Why?
| | Vasomotor System | 1 | 2013 | 43 | 0.420 |
Why?
| | Baroreflex | 1 | 2013 | 60 | 0.410 |
Why?
| | Eicosanoids | 1 | 2012 | 55 | 0.390 |
Why?
| | Xanthine Oxidase | 1 | 2011 | 78 | 0.360 |
Why?
| | NADPH Oxidases | 1 | 2011 | 108 | 0.360 |
Why?
| | Humans | 33 | 2024 | 129136 | 0.360 |
Why?
| | Progestins | 1 | 2011 | 78 | 0.360 |
Why?
| | Animals | 15 | 2024 | 34610 | 0.360 |
Why?
| | Superoxides | 2 | 2022 | 196 | 0.360 |
Why?
| | Angiotensin II | 1 | 2011 | 93 | 0.350 |
Why?
| | Reactive Oxygen Species | 2 | 2021 | 579 | 0.340 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2437 | 0.330 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1671 | 0.310 |
Why?
| | Heating | 3 | 2017 | 20 | 0.310 |
Why?
| | Estrogens | 1 | 2011 | 354 | 0.300 |
Why?
| | Inflammation | 4 | 2023 | 2668 | 0.290 |
Why?
| | Cyclic N-Oxides | 2 | 2020 | 30 | 0.290 |
Why?
| | Interleukin-1 | 2 | 2022 | 961 | 0.270 |
Why?
| | Male | 20 | 2024 | 63203 | 0.270 |
Why?
| | Forearm | 2 | 2017 | 120 | 0.260 |
Why?
| | NG-Nitroarginine Methyl Ester | 4 | 2014 | 46 | 0.260 |
Why?
| | Female | 20 | 2024 | 68519 | 0.250 |
Why?
| | Cellular Senescence | 2 | 2023 | 174 | 0.240 |
Why?
| | Age Factors | 4 | 2024 | 3120 | 0.240 |
Why?
| | Bottle-Nosed Dolphin | 1 | 2024 | 3 | 0.230 |
Why?
| | Glucose | 2 | 2020 | 983 | 0.230 |
Why?
| | Endothelial Cells | 2 | 2020 | 701 | 0.230 |
Why?
| | Flavonols | 1 | 2023 | 11 | 0.220 |
Why?
| | Adult | 13 | 2024 | 35513 | 0.220 |
Why?
| | Antioxidants | 2 | 2020 | 543 | 0.220 |
Why?
| | Regional Blood Flow | 5 | 2021 | 463 | 0.210 |
Why?
| | Tetraethylammonium | 2 | 2013 | 17 | 0.210 |
Why?
| | Butanols | 1 | 2022 | 8 | 0.210 |
Why?
| | Spin Labels | 2 | 2020 | 46 | 0.200 |
Why?
| | Sugars | 1 | 2022 | 37 | 0.200 |
Why?
| | Nitric Oxide Synthase | 2 | 2013 | 232 | 0.190 |
Why?
| | Heart Rate | 2 | 2018 | 808 | 0.190 |
Why?
| | Diet, Western | 1 | 2022 | 79 | 0.190 |
Why?
| | Ultrasonography, Doppler | 3 | 2021 | 122 | 0.190 |
Why?
| | Spirostans | 1 | 2021 | 4 | 0.190 |
Why?
| | Carotid Artery, Common | 1 | 2021 | 37 | 0.190 |
Why?
| | Feces | 1 | 2024 | 437 | 0.180 |
Why?
| | Middle Aged | 6 | 2024 | 31080 | 0.170 |
Why?
| | Interleukins | 1 | 2022 | 245 | 0.170 |
Why?
| | Reflex | 1 | 2020 | 68 | 0.170 |
Why?
| | Aged | 5 | 2024 | 22090 | 0.170 |
Why?
| | Dietary Supplements | 2 | 2023 | 532 | 0.170 |
Why?
| | C-Reactive Protein | 1 | 2022 | 397 | 0.160 |
Why?
| | Microdialysis | 3 | 2014 | 51 | 0.160 |
Why?
| | Ascorbic Acid | 1 | 2020 | 125 | 0.160 |
Why?
| | Tyrosine | 1 | 2020 | 218 | 0.160 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 201 | 0.160 |
Why?
| | Doxorubicin | 1 | 2021 | 322 | 0.160 |
Why?
| | Metabolomics | 1 | 2024 | 599 | 0.160 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 2 | 2016 | 73 | 0.150 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 59 | 0.150 |
Why?
| | Transcription Factor RelA | 1 | 2018 | 82 | 0.150 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 97 | 0.140 |
Why?
| | Exercise Tolerance | 1 | 2019 | 270 | 0.140 |
Why?
| | Muscle Contraction | 1 | 2020 | 421 | 0.140 |
Why?
| | Extracellular Matrix | 1 | 2021 | 498 | 0.140 |
Why?
| | Adolescent | 5 | 2021 | 20302 | 0.130 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2019 | 166 | 0.130 |
Why?
| | Arterial Pressure | 2 | 2017 | 118 | 0.130 |
Why?
| | Laser-Doppler Flowmetry | 2 | 2013 | 34 | 0.130 |
Why?
| | Shear Strength | 1 | 2016 | 67 | 0.130 |
Why?
| | Smoking | 2 | 2014 | 1466 | 0.130 |
Why?
| | Heat-Shock Response | 1 | 2016 | 71 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1192 | 0.130 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2016 | 91 | 0.130 |
Why?
| | Vascular Resistance | 1 | 2016 | 369 | 0.120 |
Why?
| | Healthy Volunteers | 1 | 2015 | 203 | 0.120 |
Why?
| | Time Factors | 3 | 2021 | 6518 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2018 | 718 | 0.110 |
Why?
| | Stroke Volume | 1 | 2017 | 590 | 0.110 |
Why?
| | Transdermal Patch | 1 | 2013 | 15 | 0.110 |
Why?
| | Microvessels | 1 | 2014 | 79 | 0.110 |
Why?
| | Hormone Antagonists | 1 | 2013 | 30 | 0.110 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 515 | 0.110 |
Why?
| | Administration, Cutaneous | 1 | 2013 | 123 | 0.100 |
Why?
| | Prostaglandins | 1 | 2013 | 84 | 0.100 |
Why?
| | Cognition | 1 | 2020 | 1111 | 0.100 |
Why?
| | Sex Factors | 2 | 2021 | 1953 | 0.100 |
Why?
| | Sulfaphenazole | 1 | 2012 | 3 | 0.100 |
Why?
| | Cytochrome P-450 CYP2C9 | 1 | 2012 | 20 | 0.100 |
Why?
| | Potassium Channel Blockers | 1 | 2012 | 35 | 0.100 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 41 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2020 | 1901 | 0.100 |
Why?
| | Enzyme Inhibitors | 2 | 2013 | 811 | 0.100 |
Why?
| | Rats | 1 | 2020 | 5175 | 0.100 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2013 | 208 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2011 | 45 | 0.090 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 758 | 0.090 |
Why?
| | Administration, Oral | 1 | 2013 | 759 | 0.090 |
Why?
| | Linear Models | 1 | 2013 | 816 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2018 | 4012 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1271 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2021 | 2062 | 0.080 |
Why?
| | Obesity | 1 | 2019 | 2863 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2016 | 10227 | 0.060 |
Why?
| | Healthy Aging | 1 | 2024 | 34 | 0.060 |
Why?
| | Elastic Modulus | 1 | 2024 | 123 | 0.050 |
Why?
| | Models, Animal | 1 | 2024 | 367 | 0.050 |
Why?
| | Elastin | 1 | 2021 | 78 | 0.040 |
Why?
| | Collagen | 1 | 2021 | 429 | 0.040 |
Why?
| | Sympathetic Nervous System | 1 | 2019 | 184 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2018 | 215 | 0.030 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 386 | 0.030 |
Why?
| | Skin Aging | 1 | 2013 | 20 | 0.030 |
Why?
| | Ketorolac | 1 | 2013 | 18 | 0.030 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2013 | 80 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1945 | 0.020 |
Why?
| | Electrocardiography | 1 | 2011 | 607 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 1950 | 0.020 |
Why?
| | Risk Factors | 1 | 2019 | 9769 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2011 | 4915 | 0.010 |
Why?
|
|
Brunt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|